Publication | Closed Access

Risk of Adverse Outcomes in Taiwan Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Patients Who Received Percutaneous Coronary Intervention

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseTaiwan AssociatedProton Pump InhibitorsRiskOutcomes ResearchCardiologyPharmacotherapyAcute Myocardial InfarctionPlatelet AntagonistMedicineAtherosclerosisCoronary Artery DiseaseAnesthesiology